Regrowth factors of WHO grade I skull base meningiomas following incomplete resection

J Neurosurg. 2022 Apr 22;137(6):1656-1665. doi: 10.3171/2022.3.JNS2299. Print 2022 Dec 1.

Abstract

Objective: The role of adjuvant radiation therapy following incomplete resection of WHO grade I skull base meningiomas (SBMs) is controversial, and little is known regarding the behavior of residual tumors. The authors investigated the factors that influence regrowth of residual WHO grade I SBMs following incomplete resection.

Methods: From 2005 to 2019, a total of 710 patients underwent surgery for newly diagnosed WHO grade I SBMs. The data of 115 patients (16.2%) with incomplete resection and without any adjuvant radiotherapy were retrospectively assessed during a mean follow-up of 78 months (range 27-198 months). Pre-, intra-, and postoperative clinical and molecular factors were analyzed for relevance to regrowth-free survival (RFS).

Results: Eighty patients were eligible for analysis, excluding those who were lost to follow-up (n = 10) or had adjuvant radiotherapy (n = 25). Regrowth occurred in 39 patients (48.7%), with a mean RFS of 50 months (range 3-191 months). Significant predictors of regrowth were Ki-67 proliferative index (PI) ≥ 4% (p = 0.017), Simpson resection grades IV and V (p = 0.005), and invasion of the cavernous sinus (p = 0.027) and Meckel's cave (p = 0.027). After Cox regression analysis, only Ki-67 PI ≥ 4% (hazard ratio [HR] 9.39, p = 0.003) and Simpson grades IV and V (HR 8.65, p = 0.001) showed significant deterioration of RFS. When stratified into 4 scoring groups, the mean RFSs were 110, 70, 38, and 9 months for scores 1 (Ki-67 PI < 4% and Simpson grade III), 2 (Ki-67 PI < 4% and Simpson grades IV and V), 3 (Ki-67 PI ≥ 4% and Simpson grade III), and 4 (Ki-67 PI ≥ 4% and Simpson grades IV and V), respectively. RFS was significantly longer for score 1 versus scores 2-4 (p < 0.01). Tumor consistency, histology, location, peritumoral edema, vascular encasement, and telomerase reverse transcriptase promoter mutation had no impact on regrowth.

Conclusions: Ki-67 PI and Simpson resection grade showed significant associations with RFS for WHO grade I SBMs following incomplete resection. Ki-67 PI and Simpson resection grade could be utilized to stratify the level of risk for regrowth.

Keywords: WHO grade I; incomplete resection; natural behavior; oncology; regrowth; residual tumor; skull base meningioma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Ki-67 Antigen
  • Meningeal Neoplasms* / diagnosis
  • Meningeal Neoplasms* / radiotherapy
  • Meningeal Neoplasms* / surgery
  • Meningioma* / diagnosis
  • Meningioma* / radiotherapy
  • Meningioma* / surgery
  • Neoplasm Recurrence, Local / surgery
  • Neurosurgical Procedures
  • Retrospective Studies
  • Skull Base / surgery
  • Treatment Outcome
  • World Health Organization

Substances

  • Ki-67 Antigen